Kynetec - Seeds of Opportunity: Ag Market Research Explains Global Growth

Across global agriculture, biological inputs, including biostimulants and biopesticides are gaining momentum. But nowhere is the landscape more complex, diverse, or full of untapped potential than in the Asia–Pacific (APAC) region. With vastly different farming systems, market maturity levels and regulatory environments, APAC is evolving at its own pace - and in its own direction.

Drawing on Kynetec’s farmer panels, biologicals datasets and industry feedback across APAC, here are five key insights shaping the region’s biologicals market today.

01.

China Focused on large‑scale domestic food supply, with current data coverage strongest in rice and maize. Biological adoption is emerging but still data‑limited.

02.

India & Southeast Asia Primarily subsistence‑driven farming systems where yield reliability outweighs sustainability. Biological adoption is low unless supported by robust proof of performance.

03.

Australia & Japan Highly mature, commercial, export‑focused markets. Strong consumer and retailer demand for "cleaner, greener" production is pushing growers to trial and adopt biologicals.

China is focused on large-scale domestic food supply, with current data coverage strongest in rice and maize. Biological adoption is emerging but still data-limited.

India and Southeast Asia are primarily subsistence-driven farming systems where yield reliability outweighs sustainability. Biological adoption is low unless supported by robust proof of performance.

Australia and Japan are highly mature, commercial, export-focused markets. Strong consumer and retailer demand for "cleaner, greener" production is pushing growers to trial and adopt biologicals.

Insight 02

Biostimulants remain under-measured, but the true market is much larger

Kynetec's measured value for biostimulants in APAC currently stands at AUD $74 million, but this reflects limited data availability, not true market size. Most measurements come from incidental captures within farmer panels across cereals, rice and pastures.

However, gaps remain in fruit and vegetables, where biological adoption tends to be higher. With new panel collections underway, APAC's real biologicals footprint is expected to expand significantly.

Despite the measured decline in biostimulants across the reporting period, the microorganism segment is surging with 235% growth, making it the category to watch.

Insight 03

Trust in biostimulants is still low and must be rebuilt through evidence

Feedback from Australian farmers and advisors reveals a clear pattern:

Advisors see biostimulants as unproven and lacking trustworthy performance data.
Farmers associate them with "natural methods" but remain cautious due to mixed results.
Past over-promising and under-delivering products have damaged confidence in this category.

This means the path to adoption is clear:

Rigorous local trials
Transparent claims
Strong agronomic evidence
Region-specific performance stories

Survey findings show:

Farmers and advisors agree biopesticides are effective, natural, and able to manage pests, diseases and weeds.
Users who have tried biopesticides overwhelmingly intend to continue using them.
Biopesticides are gaining traction in fruit, vegetables, horticulture and increasingly in broadacre crops.

With 117 biological products and 84 distributors already measured in APAC, biopesticides represent the strongest near-term commercial opportunity for the region.

Insight 05

Biological growth in APAC hinges on local context, especially regulation and market maturity

Different markets have different adoption barriers.

digital-agriculture-full-width-thin copy

In India and parts of Southeast Asia: food security is the priority. Biologicals must prove they can match or improve yield reliability. A rapid switch without system readiness, such as Sri Lanka's overnight ban on synthetic inputs can have severe consequences.

In Australia and Japan: export market pressures and consumer expectations drive demand for softer chemistry. Retailers and processors are pushing sustainability down the supply chain. Biological adoption is expected to grow steadily, especially for biopesticides.

In China: adoption is increasing but still emerging. Biologicals must support large-scale, high-volume production systems. Focus remains on rice, maize and staple crops.

Conclusion

APAC is moving, but not uniformly

While LATAM and Europe often dominate global biologicals conversations, the APAC region represents a significant and strategically important growth frontier. With diverse production systems, strong export markets, and increasing consumer pressure, APAC is poised for greater biological adoption.

Yet growth will not be "one size fits all." Manufacturers must match strategies to the region's unique agronomic, regulatory and cultural realities.

With the industry's largest farmer panel and expanding biological datasets, Kynetec is uniquely positioned to help companies understand where biological opportunities exist in APAC and how to capture them.